Myanmar - Completeness of infant death reporting (% of reported infant deaths to estimated infant deaths)

Completeness of infant death reporting (% of reported infant deaths to estimated infant deaths) in Myanmar was reported at 58.01 % in 2008, according to the World Bank collection of development indicators, compiled from officially recognized sources.



myanmar completeness of infant death reporting percent of reported infant deaths to estimated infant deaths wb data




We will not not share your email with third parties and you can unsubscribe at any time.
Please Paste this Code in your Website
width
height
 Preview


Completeness of infant death reporting is the number of infant deaths reported by national statistics authorities to the United Nations Statistics Division's Demography Yearbook divided by the number of infant deaths estimated by the United Nations Population Division.


Myanmar | Health

Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age)
0.7
Prevalence of anemia among women of reproductive age (% of women ages 15-49)
30.3 %
Prevalence of anemia among children (% of children under 5)
39.9 %
Prevalence of anemia among non-pregnant women (% of women ages 15-49)
30.1 %
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total)
23.8 %
Number of infant deaths
36176
Cause of death, by injury (% of total)
8.2 %
Number of under-five deaths
46284
Cause of death, by non-communicable diseases (% of total)
68 %
Number of neonatal deaths
24302
Adults (ages 15+) living with HIV
220000 Persons
AIDS estimated deaths (UNAIDS estimates)
9700
Female adults with HIV (% of population ages 15+ with HIV)
35.87 %
Prevalence of HIV, total (% of population ages 15-49)
0.8 %
Mortality rate, under-5 (per 1,000)
50
Mortality rate, under-5, female (per 1,000 live births)
44.9
Mortality rate, under-5, male (per 1,000 live births)
54.9
Under-5 mortality rate (per 1,000 live births): Q1 (lowest)
62.4
Under-5 mortality rate (per 1,000 live births): Q2
62.4
Under-5 mortality rate (per 1,000 live births): Q3
48.9
Under-5 mortality rate (per 1,000 live births): Q4
27.2
Under-5 mortality rate (per 1,000 live births): Q5 (highest)
17.2
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70
24 %
Mortality rate; neonatal (per 1;000 live births)
26.4
Demand for family planning satisfied by modern methods (% of married women with demand for family planning)
58.5 %
Children (0-14) living with HIV
9500 Persons
Prevalence of HIV, female (% ages 15-24)
0.4 %
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)
31.8
Prevalence of HIV, male (% ages 15-24)
0.4 %
Antiretroviral therapy coverage (% of people with advanced HIV infection)
47 %
Adults (ages 15+) newly infected with HIV
11000
Children (ages 0-14) newly infected with HIV
1000
Adults (ages 15+) and children (ages 0-14) newly infected with HIV
12000
Incidence of HIV (% of uninfected population ages 15-49)
0.04 %
% of females ages 15-49 having comprehensive correct knowledge about HIV (2 prevent ways and reject 3 misconceptions)
30.1 %
Children orphaned by HIV/AIDS
110000
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
77 %
Adults (ages 15+) and children (0-14 years) living with HIV
220000 Persons
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q1 (lowest)
97.3 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q2
95.7 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q3
96.8 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q4
98.4 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q5 (highest)
98.1 %
Immunization, Hib3 (% of children ages 12-23 months)
75 %
Immunization, BCG (% of one-year-old children)
86 %
Vaccinations (BCG) (% of children ages 12-23 months): Q1 (lowest)
98.6 %
Vaccinations (BCG) (% of children ages 12-23 months): Q2
97.1 %
Vaccinations (BCG) (% of children ages 12-23 months): Q3
98 %
Vaccinations (BCG) (% of children ages 12-23 months): Q4
99.1 %
Vaccinations (BCG) (% of children ages 12-23 months): Q5 (highest)
98.9 %
Immunization, DPT (% of children ages 12-23 months)
75 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q1 (lowest)
97.5 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q2
96.3 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q3
97.3 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q4
99.1 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q5 (highest)
99.2 %
Immunization, measles (% of children ages 12-23 months)
86 %
Vaccinations (Measles) (% of children ages 12-23 months): Q1 (lowest)
98.4 %
Vaccinations (Measles) (% of children ages 12-23 months): Q2
96.3 %
Vaccinations (Measles) (% of children ages 12-23 months): Q3
97.7 %
Vaccinations (Measles) (% of children ages 12-23 months): Q4
99 %
Vaccinations (Measles) (% of children ages 12-23 months): Q5 (highest)
98.4 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q1 (lowest)
0.9 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q2
2.3 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q3
1.8 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q4
0.9 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q5 (highest)
0.8 %
Immunization, Pol3 (% of one-year-old children)
76 %
Hospital beds
0.6
Community health workers
0.21
Nurses and midwives
1
Physicians
0.612
Specialist surgical workforce (per 100,000 population)
2.37
Notified cases of malaria (per 100;000 people)
7943
Incidence of malaria (per 1,000 population at risk)
11.8
Use of insecticide-treated bed nets (% of under-5 population)
11.1 %
Number of maternal mortality deaths
1700
Lifetime risk of maternal death (1 in: rate varies by country)
260
Lifetime risk of maternal death
0.3848 %
Prevalence of anemia among pregnant women
33.3 %
Prevalence of syphilis (% of women attending antenatal care)
0.6 %
Smoking prevalence, females (% of adults)
6.4 %
Smoking prevalence, males (% of adults)
31.6 %
Improved sanitation facilities (% of population with access)
79.6 %
Improved sanitation facilities, urban (% of urban population with access)
84.3 %
Pregnant women receiving prenatal care of at least four visits (% of pregnant women)
73.4 %
Antenatal care (any skilled personnel) (% of women with a birth): Q1 (lowest)
70.7 %
Antenatal care (any skilled personnel) (% of women with a birth): Q2
77.7 %
Antenatal care (any skilled personnel) (% of women with a birth): Q3
82.9 %
Antenatal care (any skilled personnel) (% of women with a birth): Q4
92.6 %
Antenatal care (any skilled personnel) (% of women with a birth): Q5 (highest)
97.4 %
Pregnant women receiving prenatal care
83.1 %
Antenatal care (doctor) (% of women with a birth): Q1 (lowest)
2 %
Antenatal care (doctor) (% of women with a birth): Q2
6.7 %
Antenatal care (doctor) (% of women with a birth): Q3
12.7 %
Antenatal care (doctor) (% of women with a birth): Q4
27.8 %
Antenatal care (doctor) (% of women with a birth): Q5 (highest)
61.6 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q1 (lowest)
62.5 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q2
65.1 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q3
72.1 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q4
75.3 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q5 (highest)
77.3 %
ARI treatment (% of children under 5 taken to a health provider)
69.3 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q1 (lowest)
3 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q2
2.3 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q3
2.9 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q4
2.6 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q5 (highest)
1.8 %
Exclusive breastfeeding (% of children under 6 months)
23.6 %
Assistance during delivery (any skilled personnel) (% of births): Q1 (lowest)
51 %
Assistance during delivery (any skilled personnel) (% of births): Q2
63.5 %
Assistance during delivery (any skilled personnel) (% of births): Q3
68.7 %
Assistance during delivery (any skilled personnel) (% of births): Q4
82.7 %
Assistance during delivery (any skilled personnel) (% of births): Q5 (highest)
96.1 %
Births attended by skilled health staff (% of total)
70.6 %
Place of delivery (births at health facility) (% of births): Q1 (lowest)
12.4 %
Place of delivery (births at health facility) (% of births): Q2
23.1 %
Place of delivery (births at health facility) (% of births): Q3
31.2 %
Place of delivery (births at health facility) (% of births): Q4
48.9 %
Place of delivery (births at health facility) (% of births): Q5 (highest)
77.5 %
Assistance during delivery (doctor) (% of births): Q1 (lowest)
7.2 %
Assistance during delivery (doctor) (% of births): Q2
13.7 %
Assistance during delivery (doctor) (% of births): Q3
21.1 %
Assistance during delivery (doctor) (% of births): Q4
40.9 %
Assistance during delivery (doctor) (% of births): Q5 (highest)
69.3 %
Low-birthweight babies (% of births)
8.6 %
Diabetes prevalence (% of population ages 20 to 79)
6.8 %
Prevalence of diarrhea (% of children under 5): Q1 (lowest)
7.8 %
Prevalence of diarrhea (% of children under 5): Q2
7.2 %
Prevalence of diarrhea (% of children under 5): Q3
6.8 %
Prevalence of diarrhea (% of children under 5): Q4
6.3 %
Prevalence of diarrhea (% of children under 5): Q5 (highest)
5 %
Prevalence of underweight, weight for age, female (% of children under 5)
22.1 %
Prevalence of underweight, weight for age, male (% of children under 5)
23 %
Malnourished children (underweight, -2SD) (% of children under 5): Q1 (lowest)
33.1 %
Malnourished children (underweight, -2SD) (% of children under 5): Q2
23.9 %
Malnourished children (underweight, -2SD) (% of children under 5): Q3
21.6 %
Malnourished children (underweight, -2SD) (% of children under 5): Q4
16.6 %
Malnourished children (underweight, -2SD) (% of children under 5): Q5 (highest)
13.5 %
Malnutrition prevalence, weight for age (% of children under 5)
22.6 %
Malaria cases reported
77842
Malnourished children (underweight, -3SD) (% of children under 5): Q1 (lowest)
9.7 %
Malnourished children (underweight, -3SD) (% of children under 5): Q2
6.3 %
Malnourished children (underweight, -3SD) (% of children under 5): Q3
4.8 %
Malnourished children (underweight, -3SD) (% of children under 5): Q4
2.9 %
Malnourished children (underweight, -3SD) (% of children under 5): Q5 (highest)
2.7 %
Maternal mortality ratio (modeled estimate, per 100,000 live births)
178
Maternal mortality ratio (national estimate; per 100;000 live births)
320
People practicing open defecation, rural (% of rural population)
6.4 %
People practicing open defecation, urban (% of urban population)
0.5 %
People practicing open defecation (% of population)
4.4 %
Diarrhea treatment (% of children under 5 receiving oral rehydration and continued feeding)
50.3 %
Diarrhea treatment (% of children under 5 who received ORS packet)
60.6 %
Prevalence of overweight, female (% of female adults)
23.3 %
Prevalence of overweight, male (% of male adults)
14.6 %
Prevalence of overweight, weight for height, female (% of children under 5)
2.6 %
Prevalence of overweight, weight for height, male (% of children under 5)
2.7 %
Prevalence of overweight (% of children under 5)
2.6 %
Malnourished children (stunting, -3SD) (% of children under 5): Q1 (lowest)
21 %
Malnourished children (stunting, -3SD) (% of children under 5): Q2
14.1 %
Malnourished children (stunting, -3SD) (% of children under 5): Q3
11.4 %
Malnourished children (stunting, -3SD) (% of children under 5): Q4
8.6 %
Malnourished children (stunting, -3SD) (% of children under 5): Q5 (highest)
5 %
Prevalence of stunting, height for age, female (% of children under 5)
33.4 %
Prevalence of stunting, height for age, male (% of children under 5)
36.7 %
Malnourished children (stunting, -2SD) (% of children under 5): Q1 (lowest)
46.6 %
Malnourished children (stunting, -2SD) (% of children under 5): Q2
39.6 %
Malnourished children (stunting, -2SD) (% of children under 5): Q3
35.7 %
Malnourished children (stunting, -2SD) (% of children under 5): Q4
27.7 %
Malnourished children (stunting, -2SD) (% of children under 5): Q5 (highest)
20.7 %
Malnutrition prevalence, height for age (% of children under 5)
35.1 %
Suicide mortality rate (per 100,000 population)
4.3
Mortality caused by road traffic injury (per 100,000 people)
19.5
Prevalence of wasting, weight for height, female (% of children under 5)
7.1 %
Prevalence of wasting, weight for height, male (% of children under 5)
8.7 %
Malnourished children (wasting, -2SD) (% of children under 5): Q1 (lowest)
9.9 %
Malnourished children (wasting, -2SD) (% of children under 5): Q2
7.8 %
Malnourished children (wasting, -2SD) (% of children under 5): Q3
7.1 %
Malnourished children (wasting, -2SD) (% of children under 5): Q4
7.2 %
Malnourished children (wasting, -2SD) (% of children under 5): Q5 (highest)
6.9 %
Prevalence of wasting (% of children under 5)
7.9 %
Malnourished children (wasting, -3SD) (% of children under 5): Q1 (lowest)
2.9 %
Malnourished children (wasting, -3SD) (% of children under 5): Q2
2.2 %
Malnourished children (wasting, -3SD) (% of children under 5): Q3
1.8 %
Malnourished children (wasting, -3SD) (% of children under 5): Q4
1.8 %
Malnourished children (wasting, -3SD) (% of children under 5): Q5 (highest)
1.8 %
Prevalence of severe wasting, weight for height, female (% of children under 5)
1.9 %
Prevalence of severe wasting, weight for height, male (% of children under 5)
2.4 %
Prevalence of severe wasting, weight for height (% of children under 5)
2.1 %
Tuberculosis treatment success rate (% of registered cases)
87 %
Tuberculosis case detection rate (all forms)
70
Incidence of tuberculosis (per 100,000 people)
365
Tuberculosis death rate (per 100,000 people)
49
Newborns protected against tetanus
87 %
External resources for health (% of total expenditure on health)
21.81 %
Out-of-pocket health expenditure (% of total expenditure on health)
50.69 %
Out-of-pocket health expenditure (% of private expenditure on health)
93.72 %
Health expenditure per capita
20.29 USD
Health expenditure per capita, PPP (constant 2005 international $)
103
Health expenditure, private (% of GDP)
1.23 %
Health expenditure, public (% of total health expenditure)
45.91 %
Health expenditure, public (% of government expenditure)
3.59 %
Health expenditure, public (% of GDP)
1.04 %
Health expenditure, total (% of GDP)
2.28 %
Refugee population by country or territory of asylum
0
Refugee population by country or territory of origin
451807
Number of people who are undernourished
7700000
Prevalence of undernourishment (% of population)
14.2 %
Depth of the food deficit (kilocalories per person per day)
103
Depth of hunger (kilocalories per person per day)
230
Consumption of iodized salt (% of households)
68.8 %
Vitamin A supplements for postpartum women (% of women with a birth): Q1 (lowest)
64.3 %
Vitamin A supplements for postpartum women (% of women with a birth): Q2
65.7 %
Vitamin A supplements for postpartum women (% of women with a birth): Q3
69.4 %
Vitamin A supplements for postpartum women (% of women with a birth): Q4
69.7 %
Vitamin A supplements for postpartum women (% of women with a birth): Q5 (highest)
63.6 %
Vitamin A supplements for children (% of children ages 6-59 months): Q1 (lowest)
53.7 %
Vitamin A supplements for children (% of children ages 6-59 months): Q2
59.8 %
Vitamin A supplements for children (% of children ages 6-59 months): Q3
57.7 %
Vitamin A supplements for children (% of children ages 6-59 months): Q4
58.1 %
Vitamin A supplements for children (% of children ages 6-59 months): Q5 (highest)
50.6 %
Vitamin A supplementation coverage rate (% of children ages 6-59 months)
94 %
Adolescent fertility rate (births per 1,000 women ages 15-19)
16.25
Completeness of infant death reporting (% of reported infant deaths to estimated infant deaths)
58.01 %
Completeness of total death reporting (% of reported total deaths to estimated total deaths)
100 %
Mortality rate, adult, female (per 1,000 female adults)
171
Mortality rate, adult, male (per 1,000 male adults)
228
Birth rate, crude
17.49
Death rate, crude
8.26
Current use of contraception (modern method) (% of married women): Q1 (lowest)
37.9 %
Current use of contraception (modern method) (% of married women): Q2
44.6 %
Current use of contraception (modern method) (% of married women): Q3
45.1 %
Current use of contraception (modern method) (% of married women): Q4
50 %
Current use of contraception (modern method) (% of married women): Q5 (highest)
51 %
Contraceptive prevalence, modern methods (% of women ages 15-49)
45.8 %
Current use of contraception (any method) (% of married women): Q1 (lowest)
38.3 %
Current use of contraception (any method) (% of married women): Q2
44.9 %
Current use of contraception (any method) (% of married women): Q3
45.4 %
Current use of contraception (any method) (% of married women): Q4
50.2 %
Current use of contraception (any method) (% of married women): Q5 (highest)
51.7 %
Contraceptive prevalence (% of women ages 15-49)
46 %
Mortality rate, infant, female (per 1,000 live births)
34.9
Mortality rate, infant (per 1,000 live births)
39.5
Mortality rate, infant, male (per 1,000 live births)
43.8
Infant mortality rate (per 1,000 live births): Q1 (lowest)
49.2
Infant mortality rate (per 1,000 live births): Q2
52.2
Infant mortality rate (per 1,000 live births): Q3
40.4
Infant mortality rate (per 1,000 live births): Q4
23.5
Infant mortality rate (per 1,000 live births): Q5 (highest)
13.2
Life expectancy at birth, female (years)
68.16 years
Life expectancy at birth, total (years)
66.04 years
Life expectancy at birth, male (years)
64.03 years
Fertility rate, total (births per woman)
2.18
Survival to age 65, female (% of cohort)
71.57 %
Survival to age 65, male (% of cohort)
62.97 %
Female population 00-04
2237000 Persons
Population ages 0-4, female (% of female population)
8.21 %
Male population 00-04
2274000 Persons
Population ages 0-4, male (% of male population)
8.74 %
Female population 05-09
2429000 Persons
Population ages 5-9, female (% of female population)
8.99 %
Male population 05-09
2463000 Persons
Population ages 5-9, male (% of male population)
9.54 %
Female population 10-14
2623000 Persons
Population ages 10-14, female (% of female population)
9.56 %
Male population 10-14
2652000 Persons
Population ages 10-14, male (% of male population)
10.11 %
Female population 15-19
2522000 Persons
Population ages 15-19, female (% of female population)
9.03 %
Male population 15-19
2531000 Persons
Population ages 15-19, male (% of male population)
9.47 %
Female population 20-24
2349000 Persons
Population ages 20-24, female (% of female population)
8.42 %
Male population 20-24
2332000 Persons
Population ages 20-24, male (% of male population)
8.73 %
Female population 25-29
2200000 Persons
Population ages 25-29, female (% of female population)
7.93 %
Male population 25-29
2152000 Persons
Population ages 25-29, male (% of male population)
8.12 %
Female population 30-34
2139000 Persons
Population ages 30-34, female (% of female population)
7.75 %
Male population 30-34
2108000 Persons
Population ages 30-34, male (% of male population)
7.99 %
Female population 35-39
2068000 Persons
Population ages 35-39, female (% of female population)
7.44 %
Male population 35-39
1995000 Persons
Population ages 35-39, male (% of male population)
7.48 %
Female population 40-44
1914000 Persons
Population ages 40-44, female (% of female population)
6.84 %
Male population 40-44
1805000 Persons
Population ages 40-44, male (% of male population)
6.74 %
Female population 45-49
1735000 Persons
Population ages 45-49, female (% of female population)
6.18 %
Male population 45-49
1602000 Persons
Population ages 45-49, male (% of male population)
5.96 %
Female population 50-54
1501000 Persons
Population ages 50-54, female (% of female population)
5.33 %
Male population 50-54
1348000 Persons
Population ages 50-54, male (% of male population)
4.99 %
Female population 55-59
1286000 Persons
Population ages 55-59, female (% of female population)
4.58 %
Male population 55-59
1118000 Persons
Population ages 55-59, male (% of male population)
4.16 %
Female population 60-64
1082000 Persons
Population ages 50-64, female (% of female population)
3.78 %
Male population 60-64
888000 Persons
Population ages 50-64, male (% of male population)
3.25 %
Female population 65-69
682000 Persons
Population ages 65-69, female (% of female population)
2.3 %
Male population 65-69
554000 Persons
Population ages 65-69, male (% of male population)
1.97 %
Population ages 65 and above (% of total)
5.36 %
Female population 70-74
452000 Persons
Population ages 70-74, female (% of female population)
1.62 %
Male population 70-74
355000 Persons
Population ages 70-74, male (% of male population)
1.33 %
Female population 75-79
307000 Persons
Population ages 75-79, female (% of female population)
1.11 %
Male population 75-79
222000 Persons
Population ages 75-79, male (% of male population)
0.8313 %
Population ages 80 and above, female
270000 Persons
Population ages 80 and above, female (% of female population)
0.935 %
Male population 80+
169000 Persons
Population ages 80 and above, male (% of male population)
0.6063 %
Age population, age 06, female, interpolated
486257 Persons
Age population, age 06, male, interpolated
493204 Persons
Age population, age 07, female, interpolated
495860 Persons
Age population, age 07, male, interpolated
502721 Persons
Age population, age 08, female, interpolated
505013 Persons
Age population, age 08, male, interpolated
511763 Persons
Age population, age 09, female, interpolated
513321 Persons
Age population, age 09, male, interpolated
519913 Persons
Age population, age 10, female, interpolated
521237 Persons
Age population, age 10, male
527640 Persons
Age population, age 11, female, interpolated
529213 Persons
Age population, age 11, male
535407 Persons
Age population, age 12, female, interpolated
532619 Persons
Age population, age 12, male
538408 Persons
Age population, age 13, female, interpolated
529370 Persons
Age population, age 13, male
534474 Persons
Age population, age 14, female, interpolated
521610 Persons
Age population, age 14, male
525826 Persons
Age population, age 15, female, interpolated
513650 Persons
Age population, age 15, male, interpolated
516953 Persons
Age population, age 16, female, interpolated
504728 Persons
Age population, age 16, male, interpolated
507065 Persons
Age population, age 17, female, interpolated
496302 Persons
Age population, age 17, male, interpolated
497616 Persons
Age population, age 18, female, interpolated
489568 Persons
Age population, age 18, male, interpolated
489812 Persons
Age population, age 19, female, interpolated
483866 Persons
Age population, age 19, male, interpolated
483003 Persons
Age population, age 20, female, interpolated
477426 Persons
Age population, age 20, male, interpolated
475487 Persons
Age population, age 21, female, interpolated
470715 Persons
Age population, age 21, male, interpolated
467792 Persons
Age population, age 22, female, interpolated
464128 Persons
Age population, age 22, male, interpolated
460058 Persons
Age population, age 23, female, interpolated
457724 Persons
Age population, age 23, male, interpolated
452245 Persons
Age population, age 24, female, interpolated
451618 Persons
Age population, age 24, male, interpolated
444645 Persons
Age population, age 25, female, interpolated
445669 Persons
Age population, age 25, male, interpolated
437211 Persons
Age dependency ratio (% of working-age population)
49.05 %
Age dependency ratio, old (% of working-age population)
7.99 %
Age dependency ratio, young (% of working-age population)
41.07 %
Population, female (% of total)
51.14 %
Completeness of birth registration, rural
63.5 %
Completeness of birth registration, urban
93.5 %
Completeness of birth registration
72.4 %
Unmet need for contraception (% of married women ages 15-49)
19.1 %